Hematologic Neoplasms: all 1,494 studies

Page 7 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.

• Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two StepsTerminatedNCT01350258Phase 1/2Results posted
• A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related DonorsCompletedNCT01349101Phase 2Results posted
• Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple MyelomaCompletedNCT01345019Phase 3Results posted
• Phase I Study of OPB-51602 in Patients With Hematologic MalignanciesCompletedNCT01344876Phase 1Results posted
• Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesCompletedNCT01341301Phase 2Results posted
• Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative RegimenCompletedNCT01328496Phase 2Results posted
• Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced CancerCompletedNCT01324323Phase 1Results posted
• Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced CancerCompletedNCT01324310Phase 1Results posted
• A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological MalignanciesCompletedNCT01315132Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)CompletedNCT01254630Phase 3Results posted
• Umbilical Cord Blood Transplant for Children With Myeloid Hematological MalignanciesCompletedNCT01247701Not applicableResults posted
• Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCTCompletedNCT01246206Phase 2Results posted
• Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) TransplantCompletedNCT01244906Phase 2Results posted
• Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell TransplantCompletedNCT01231412Phase 3Results posted
• Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological MalignanciesCompletedNCT01221857Phase 1/2Results posted
• Influenza Vaccine Post Allogeneic TransplantTerminatedNCT01215981Not applicableResults posted
• Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic MalignanciesCompletedNCT01203722Phase 1/2Results posted
• Cytokine Induced Killer (CIK) Cells In Leukemia PatientsCompletedNCT01186809Phase 2Results posted
• Reduced Intensity Haploidentical Transplant for Hematological MalignanciesCompletedNCT01162096Phase 1/2Results posted
• Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)TerminatedNCT01139164Phase 2Results posted
• HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic MalignanciesCompletedNCT01119066Phase 2Results posted
• Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT01093586Phase 2Results posted
• Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological MalignanciesCompletedNCT01084252Phase 1/2Results posted
• A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic MalignanciesCompletedNCT01036009Phase 2Results posted
• Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTerminatedNCT01028716Phase 2Results posted
• The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised ParticipantsCompletedNCT01021683Results posted
• Mismatched Transplantation Using High-dose Post-transplant CyclophosphamideCompletedNCT01010217Phase 2Results posted
• Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure StatesCompletedNCT00997386Phase 2Results posted
• Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic MalignanciesCompletedNCT00988013Not applicableResults posted
• Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell TransplantationTerminatedNCT00984165Phase 2Results posted
• Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood CancerCompletedNCT00975975Phase 2Results posted
• Trial of Pimasertib in Hematological MalignanciesTerminatedNCT00957580Phase 2Results posted
• A Study Of PF-04449913 In Select Hematologic MalignanciesCompletedNCT00953758Phase 1Results posted
• Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic MalignanciesCompletedNCT00943592Phase 1/2Results posted
• Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic MalignanciesCompletedNCT00943319Phase 1/2Results posted
• Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological MalignanciesCompletedNCT00914849Phase 2Results posted
• Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) PatientsCompletedNCT00824993Phase 3Results posted
• Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell TransplantCompletedNCT00810602Phase 1/2Results posted
• Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic MalignanciesCompletedNCT00795132Phase 2Results posted
• Trial Of Double Umbilical Cord Blood TransplantationCompletedNCT00763490Phase 2Results posted
• Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)CompletedNCT00750737Phase 3Results posted
• A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple MyelomaCompletedNCT00742560Phase 2Results posted
• Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic MalignanciesCompletedNCT00741455Not applicableResults posted
• Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.CompletedNCT00739141Phase 2Results posted
• Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell TransplantationTerminatedNCT00698685Phase 2Results posted
• Study of MLN8237 in Participants With Advanced Hematological MalignanciesCompletedNCT00697346Phase 1Results posted
• Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic MalignanciesTerminatedNCT00689884Not applicableResults posted
• T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedNCT00683046Phase 2Results posted
• INCB018424 in Patients With Advanced Hematologic MalignanciesCompletedNCT00674479Phase 2Results posted
• Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk MalignanciesCompletedNCT00673114Phase 1/2Results posted
• A Study of Oral LBH589 in Adult Patients With Advanced Hematological MalignanciesCompletedNCT00621244Phase 1/2Results posted
• Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative ConditioningsCompletedNCT00603954Phase 2Results posted
• A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological MalignancyCompletedNCT00597519Phase 2Results posted
• Phase 2 Haplotype Mismatched HSCT in Patients With Hematological MalignanciesTerminatedNCT00593554Phase 2Results posted
• Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological DiseasesCompletedNCT00582894Not applicableResults posted
• Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan RegimenCompletedNCT00556452Phase 1/2Results posted
• Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)TerminatedNCT00519090Phase 3Results posted
• Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)TerminatedNCT00506948Phase 2Results posted
• Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell SupportCompletedNCT00506857Phase 1/2Results posted
• Fatigue in Emergency Center PatientsTerminatedNCT00504985Results posted
• Intermittent Use of Aerosolized Ribavirin for Treatment of RSVCompletedNCT00500578Phase 4Results posted
• Phase II Trial of Pentostatin and Targeted BusulfanCompletedNCT00496340Phase 2Results posted
• Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell TransplantationCompletedNCT00429416Phase 1/2Results posted
• A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched RelativeCompletedNCT00429143Phase 1/2Results posted
• Voraxaze for Delayed Methotrexate ClearanceTerminatedNCT00424645Phase 1/2Results posted
• A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of MalignanciesCompletedNCT00402714Phase 2Results posted
• Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory CancerTerminatedNCT00387153Phase 1Results posted
• Rituximab for Prevention of Chronic GVHDCompletedNCT00379587Phase 1/2Results posted
• Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell TransplantationCompletedNCT00369226Phase 1/2Results posted
• Study of Immune Response Modifier in the Treatment of Hematologic MalignanciesTerminatedNCT00276159Phase 2Results posted
• Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological MalignanciesCompletedNCT00241358Phase 1/2Results posted
• Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)CompletedNCT00231309Not applicableResults posted
• G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure SyndromeTerminatedNCT00228813Not applicableResults posted
• Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) TransplantationCompletedNCT00189488Phase 2Results posted
• Allogeneic Transplantation From Related Haploidentical DonorsCompletedNCT00185692Phase 2Results posted
• Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic MalignanciesCompletedNCT00185640Phase 2Results posted
• Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple MyelomaCompletedNCT00185614Phase 2Results posted
• Stem Cell Transplant for Hematological MalignancyTerminatedNCT00176930Not applicableResults posted
• Stem Cell Transplantation for Hematological MalignanciesTerminatedNCT00176839Phase 2/3Results posted
• Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological MalignanciesCompletedNCT00150462Phase 1Results posted
• HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic MalignanciesCompletedNCT00145626Phase 2Results posted
• A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic MalignanciesCompletedNCT00109707Phase 1/2Results posted
• Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow MalignanciesCompletedNCT00079391Phase 2Results posted
• Stem Cell Transplant for Hematologic DiseasesTerminatedNCT00058825Phase 1/2Results posted
• Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System CancersCompletedNCT00051311Phase 2Results posted
• Animal-Assisted Intervention for Children With Cancer and Their SiblingsCompletedNCT07861620Not applicable
• Murottal as Adjunctive Intervention in PediatricCompletedNCT07861477Not applicable
• A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In GreeceActive, not recruitingNCT07814170Not applicable
• ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative AnalysisCompletedNCT07712835
• Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 PatientsActive, not recruitingNCT07709637Phase 1
• Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During Admission in the Laminar Flow ChamberCompletedNCT07462962
• The Effect of Relaxation Breathing Exercise on Chemotherapy Induced Nausea and VomitingActive, not recruitingNCT07456982Not applicable
• Expressive Writing Program Among Young Adults With Blood CancerActive, not recruitingNCT07413991Not applicable
• Coverage and Cost of Care Links- TelehealthCompletedNCT07409662Not applicable
• Comparative Effectiveness of Verbal Instruction Versus Simulation Video Education Among Cancer Patients Undergoing Radiation TherapyCompletedNCT07367997Not applicable
• CD70.CAR for CD70+ Lymphoma, Myeloma and Solid TumorsWithdrawnNCT07297160Phase 1
• Progressive Relaxation and Psychoeducation in Patients With Hematological MalignanciesActive, not recruitingNCT07251348Not applicable
• Impact of Congenital Heart Disease on the Prognosis of Childhood Hematological Neoplasms: A Multicenter Cohort StudyCompletedNCT07249138
• Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT PatientsCompletedNCT07200583
• Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T CellsWithdrawnNCT07071909Phase 1/2

← Hematologic Neoplasms overview